Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

4,136 studies matching your filters

A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia AreataRecruiting
NCT07772492Phase 3Updated Aug 21, 2026
Sponsor: AbbVie
Severe Alopecia Areata
United States
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)Recruiting
NCT05920356Phase 3Updated Aug 21, 2026
Sponsor: Amgen
Non-Small Cell Lung Cancer (NSCLC)
United States, Argentina, Australia, Austria, Belgium +33 more
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)Recruiting
NCT05065216Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: DiaMedica Therapeutics Inc
Acute Stroke · Ischemic Stroke · Stroke
United States, Belgium, Canada, France, Georgia +5 more
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaRecruiting
NCT06337318Phase 3Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Classic Follicular Lymphoma · Follicular Lymphoma With Unusual Cytological Features
United States
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial CancerRecruiting
NCT07198074Phase 3Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Endometrial Carcinoma · Recurrent Endometrial Carcinoma
United States
Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSHRecruiting
NCT02716246Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: Ultragenyx Pharmaceutical Inc
MPS IIIA · Sanfilippo Syndrome · Sanfilippo A · Mucopolysaccharidosis III
United States, Australia, Spain
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Recruiting
NCT06925737Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Prostate Cancer · Prostatic Neoplasms
United States, Argentina, Australia, Austria, Brazil +30 more
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingRecruiting
NCT07613307Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Diabetes Mellitus, Type 2 · Diabetes Melletus · Glucose Metabolism Disorders · Metabolic Disorders
India, Saudi Arabia, South Africa, United Arab Emirates
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)Recruiting
NCT07222332Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Diabetes Mellitus, Type 1
United States, Australia, Belgium, Brazil, Canada +15 more
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTORecruiting
NCT07734844Phase 3Updated Aug 21, 2026
Sponsor: Kodiak Sciences Inc
Diabetic Macular Edema (DME)
United States
Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT ImagingRecruiting
NCT04943211Phase 3Updated Aug 21, 2026
Sponsor: Anna Raciborska
Histiocytosis
Poland
Phase 3 Study of LUM-201 in Children With Growth Hormone DeficiencyRecruiting
NCT06948214Phase 3Updated Aug 21, 2026
Sponsor: Lumos Pharma
Growth Hormone Deficiency (GHD)
United States, Argentina, Australia, Chile, India +3 more
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical TrialRecruiting
NCT07567040Phase 3Updated Aug 21, 2026
Sponsor: Ohio State University
Myopia
United States
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)Recruiting
NCT07581002Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: AbbVie
Acute Myeloid Leukemia
United States, Austria, France, Israel, South Korea +1 more
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPRecruiting
NCT07091630Phase 3Updated Aug 21, 2026
Sponsor: argenx
Chronic Inflammatory Demyelinating Polyneuropathy · CIDP · Chronic Inflammatory Demyelinating Polyradiculoneuropathy
United States, Argentina, Austria, Brazil, Bulgaria +19 more
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)Recruiting
NCT07357727Phase 3Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (PPV-MF) · Post-essential Thrombocythemia Myelofibrosis (PET-MF)
United States, Argentina, Australia, China, India +4 more
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerRecruiting
NCT07213804Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Ovarian Neoplasms · Fallopian Tube Neoplasms · Peritoneal Neoplasms · Neoplasm Metastasis
United States, Australia, Austria, Belgium, Brazil +22 more
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)Recruiting
NCT06531824Phase 3Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Kidney Disease, Chronic
United States, Argentina, Australia, Belgium, Brazil +15 more
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruiting
NCT06937099Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Crohn's Disease · Obesity or Overweight
United States, Austria, Belgium, Brazil, Bulgaria +17 more
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyRecruiting
NCT06154252Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: Cabaletta Bio
Idiopathic Inflammatory Myopathy · Dermatomyositis · Anti-Synthetase Syndrome · Immune-Mediated Necrotizing Myopathy
United States, United Kingdom
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)Recruiting
NCT07634471Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Follicular Lymphoma
United States, Argentina, Australia, Israel, Spain +2 more
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)Recruiting
NCT07157774Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Elevated Lp(a) · Atherosclerotic Cardiovascular Disease (ASCVD)
United States, Argentina, Australia, Austria, Belgium +23 more
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Recruiting
NCT05519085Phase 3Updated Aug 21, 2026
Sponsor: Celgene
Relapsed or Refractory Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +24 more
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerRecruiting
NCT07061977Phase 3Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Locally Advanced Cervical Adenocarcinoma · Locally Advanced Cervical Adenosquamous Carcinoma · Locally Advanced Cervical Squamous Cell Carcinoma · Stage IIIA Cervical Cancer FIGO 2018
United States
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery DiseaseRecruiting
NCT07223593Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Peripheral Arterial Disease
United States, Argentina, Australia, Brazil, Canada +11 more

4,136 studies found